Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 2 | 2023 | 134 | 0.870 |
Why?
|
| Sexual and Gender Minorities | 2 | 2021 | 138 | 0.790 |
Why?
|
| Headache | 1 | 2023 | 132 | 0.790 |
Why?
|
| Headache Disorders, Primary | 1 | 2021 | 2 | 0.770 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 3 | 0.770 |
Why?
|
| Headache Disorders, Secondary | 1 | 2021 | 3 | 0.770 |
Why?
|
| White Matter | 2 | 2020 | 104 | 0.730 |
Why?
|
| Hormone Replacement Therapy | 1 | 2021 | 77 | 0.720 |
Why?
|
| Drug Interactions | 1 | 2021 | 338 | 0.680 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 52 | 0.660 |
Why?
|
| Brain Diseases | 1 | 2020 | 124 | 0.640 |
Why?
|
| Cytomegalovirus Infections | 1 | 2020 | 180 | 0.600 |
Why?
|
| Hearing Loss | 1 | 2020 | 183 | 0.560 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 1394 | 0.550 |
Why?
|
| Neurology | 3 | 2023 | 84 | 0.530 |
Why?
|
| Brain | 2 | 2023 | 2371 | 0.430 |
Why?
|
| Testosterone | 2 | 2023 | 343 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 3039 | 0.230 |
Why?
|
| Sertraline | 2 | 2013 | 26 | 0.210 |
Why?
|
| Brain Mapping | 2 | 2023 | 524 | 0.180 |
Why?
|
| Headache Disorders | 1 | 2020 | 12 | 0.180 |
Why?
|
| Migraine Disorders | 1 | 2021 | 82 | 0.180 |
Why?
|
| Estrogens | 1 | 2023 | 312 | 0.180 |
Why?
|
| Neuroimaging | 2 | 2020 | 249 | 0.170 |
Why?
|
| Depressive Disorder, Major | 2 | 2013 | 301 | 0.170 |
Why?
|
| Hearing Tests | 1 | 2020 | 50 | 0.170 |
Why?
|
| Transition to Adult Care | 1 | 2020 | 62 | 0.170 |
Why?
|
| Sex Distribution | 1 | 2020 | 337 | 0.170 |
Why?
|
| Research Personnel | 1 | 2020 | 149 | 0.160 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2020 | 104 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2020 | 152 | 0.160 |
Why?
|
| Career Choice | 1 | 2020 | 177 | 0.150 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 380 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3003 | 0.150 |
Why?
|
| Prevalence | 1 | 2023 | 2249 | 0.140 |
Why?
|
| Sex Characteristics | 2 | 2012 | 640 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 2387 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2762 | 0.130 |
Why?
|
| Retrospective Studies | 2 | 2023 | 12542 | 0.120 |
Why?
|
| Humans | 12 | 2023 | 114623 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2020 | 585 | 0.120 |
Why?
|
| Antidepressive Agents | 2 | 2013 | 195 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2021 | 892 | 0.110 |
Why?
|
| Prospective Studies | 2 | 2023 | 6217 | 0.110 |
Why?
|
| Gyrus Cinguli | 1 | 2013 | 70 | 0.110 |
Why?
|
| Puberty | 2 | 2012 | 135 | 0.100 |
Why?
|
| Pediatrics | 1 | 2020 | 979 | 0.100 |
Why?
|
| Gray Matter | 1 | 2013 | 67 | 0.100 |
Why?
|
| Personality Inventory | 1 | 2012 | 131 | 0.100 |
Why?
|
| Sexual Maturation | 1 | 2012 | 47 | 0.100 |
Why?
|
| Temporal Lobe | 1 | 2012 | 79 | 0.100 |
Why?
|
| Adolescent | 4 | 2023 | 17831 | 0.090 |
Why?
|
| Child | 4 | 2023 | 18404 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2020 | 5043 | 0.080 |
Why?
|
| Infant | 1 | 2020 | 7959 | 0.070 |
Why?
|
| Adult | 2 | 2023 | 30528 | 0.060 |
Why?
|
| Male | 6 | 2020 | 55554 | 0.050 |
Why?
|
| Female | 5 | 2020 | 59466 | 0.050 |
Why?
|
| Social Stigma | 1 | 2021 | 87 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 222 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 927 | 0.040 |
Why?
|
| Consensus | 1 | 2020 | 537 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 663 | 0.030 |
Why?
|
| Burnout, Professional | 1 | 2020 | 322 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2013 | 109 | 0.030 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 8 | 0.030 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 14 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 434 | 0.020 |
Why?
|
| Age of Onset | 1 | 2013 | 445 | 0.020 |
Why?
|
| Frontal Lobe | 1 | 2012 | 141 | 0.020 |
Why?
|
| Amygdala | 1 | 2012 | 170 | 0.020 |
Why?
|
| Reaction Time | 1 | 2012 | 376 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2012 | 261 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 9084 | 0.020 |
Why?
|
| Psychometrics | 1 | 2012 | 608 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2012 | 476 | 0.020 |
Why?
|
| Hippocampus | 1 | 2012 | 693 | 0.020 |
Why?
|
| Sex Factors | 1 | 2012 | 1715 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 10455 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 2894 | 0.020 |
Why?
|
| Aged | 2 | 2013 | 19061 | 0.020 |
Why?
|
| Middle Aged | 1 | 2012 | 26719 | 0.010 |
Why?
|